Medicinova inc (MNOV)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:
License revenue

-

-

-

-

-

-

6,000

-

-

-

-

Research and development service revenue

-

-

-

-

-

-

3

802

-

-

-

Operating expenses:
Research, development and patents

6,079

5,625

4,223

3,519

3,017

3,259

3,365

5,013

7,784

9,710

10,873

General and administrative

7,952

9,961

8,803

7,362

5,805

5,963

6,657

6,734

8,323

8,171

10,366

Total operating expenses

14,031

15,586

13,027

10,881

8,822

9,223

10,023

11,747

16,108

17,882

21,239

Operating loss

-14,031

-15,586

-13,027

-10,881

-8,822

-9,223

-4,020

-10,945

-16,108

-17,882

-21,239

Interest income

1,148

939

145

66

39

36

20

24

62

438

823

Other income (expense)

-46

-22

-25

-47

54

12

24

29

81

176

13

Impairment charge on investment securities

-

-

-

-

-

-

-

-

-

-785

310

Interest expense

-

-

-

-

0

0

-

-

1,595

1,768

242

Loss before income taxes

-12,928

-14,669

-12,907

-10,862

-8,837

-9,199

-4,024

-10,950

-17,722

-20,174

-20,361

Income tax (expense)

12

5

-1,744

3

7

-3

4

11

11

12

7

Net loss applicable to common stockholders

-12,941

-14,675

-11,163

-10,865

-8,845

-9,195

-

-

-17,734

-20,187

-20,368

Net loss applicable to common stockholders

-

-

-

-

-

-

-4,028

-10,961

-17,734

-20,187

-20,368

Basic and diluted net loss per common share

-0.30

-0.36

-0.32

-0.33

-0.33

-0.38

-0.19

-0.66

-1.20

-1.63

-1.68

Shares used to compute basic and diluted net loss per common share

43,158

41,124

35,137

32,986

26,578

24,067

20,697

16,522

14,813

12,410

12,105

Net loss applicable to common stockholders

-12,941

-14,675

-11,163

-10,865

-8,845

-9,195

-

-

-17,734

-20,187

-20,368

Net loss applicable to common stockholders

-

-

-

-

-

-

-4,028

-10,961

-17,734

-20,187

-20,368

Other comprehensive loss, net of tax:
Foreign currency translation adjustments

0

1

1

6

-1

-20

-12

-11

-1

-

-

Comprehensive loss

-12,941

-14,673

-11,161

-10,859

-8,846

-9,215

-4,041

-10,972

-17,735

-

-